Atypical fibroxanthoma: A clinicopathological study of 89 cases

Australasian Journal of Dermatology

Volumn 46, Issue 4, 2005, Pages 235-238

  Mirza, Basit ^a,c   Weedon, David ^b  

^a MATER ADULT HOSPITAL   (Australia)

^b SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

^c Department of Dermatology ^*  (Australia)

Author keywords

CD10; CD99; Malignant fibrous histiocytoma; Metastasis; Recurrence; Skin cancer; Squamous cell carcinoma

Indexed keywords

CD99 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

ADULT; AGED; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RECURRENCE; FEMALE; FIBROXANTHOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; REVIEW; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ARTICLE; DERMATOFIBROMA; FOLLOW UP; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; SKIN TUMOR; SUNLIGHT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; MALE; MIDDLE AGED; SKIN NEOPLASMS; SUNLIGHT;

EID: 33644842889     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2005.00190.x     Document Type: Review

References (14)

1. Helwig EB. Atypical fibroxanthoma. Tex. J. Med. 1963 59 : 664 7.
2. Bourne RG. Paradoxical fibrosarcoma of skin (pseudosarcoma): a review of 13 cases. Med. J. Aust. 1963 1 : 504 10.
3. Zelger B, Soyer HP. Between Scylla and Charybdis: mythology in dermatopathology. Dermatopathol. Pract. Concept. 2000 6 : 348 55.
4. Weedon D. Tumors and tumor-like proliferations of fibrous and related tissues. In: Skin Pathology, 2nd edn. London : Churchill Livingstone, 2002 917 54.
5. Helwig EB, May D. Atypical fibroxanthoma of the skin with metastasis. Cancer 1986 57 : 368 76.
6. Davis JL, Randle HW, Zalle MJ, Roenigk RK, Brodland DG. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma. J. Dermatol. Surg. 1997 23 : 105 10.
7. Kroe DJ, Pitcock JA. Atypical fibroxanthoma of the skin. Report of ten cases. Am. J. Clin. Pathol. 1969 51 : 487 92.
8. Weedon D, Williamson R, Mirza B. CD 10 - a useful marker for AFX (Letter). Am. J. Dermatopathol. 2005 27 : 181.
9. Kemp JD, Stenn KS, Arons M, Fischer J. Metastasizing atypical fibroxanthoma. Coexistence with chronic lymphocytic leukaemia. Arch. Dermatol. 1978 114 : 1533 5.
10. Kargi E, Gungor E, Verdi M, Kuiacogiu S, Erdogan B, Alli N, Altunkaya SA. Atypical fibroxanthoma and metastasis to the lung. Plast. Reconstr. Surg. 2003 111 : 1760 2.
11. Rizzardi C, Angiero F, Melato M. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin. Anticancer Res. 2003 23 : 1847 51.
12. Guenthner ST, Hurwitz RM, Buckel LJ, Gray HR. Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: a clinicopathologic correlation. J. Am. Acad. Dermatol. 1999 41 : 443 8.
13. Fretzin DF, Helwig EB. Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer 1973 31 : 1541 52.
14. Monteagudo C, Calduch L, Navarro S. Immunomodulation of CD99 in atypical fibroxanthoma: a helpful diagnostic marker. Am. J. Dermatopathol. 2000 22 : 351.